1. Home
  2. MI vs RLYB Comparison

MI vs RLYB Comparison

Compare MI & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MI
  • RLYB
  • Stock Information
  • Founded
  • MI 2009
  • RLYB 2018
  • Country
  • MI Hong Kong
  • RLYB United States
  • Employees
  • MI N/A
  • RLYB N/A
  • Industry
  • MI Catalog/Specialty Distribution
  • RLYB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MI Consumer Discretionary
  • RLYB Health Care
  • Exchange
  • MI Nasdaq
  • RLYB Nasdaq
  • Market Cap
  • MI 21.7M
  • RLYB 24.1M
  • IPO Year
  • MI N/A
  • RLYB 2021
  • Fundamental
  • Price
  • MI $3.61
  • RLYB $0.59
  • Analyst Decision
  • MI
  • RLYB Hold
  • Analyst Count
  • MI 0
  • RLYB 2
  • Target Price
  • MI N/A
  • RLYB N/A
  • AVG Volume (30 Days)
  • MI 49.5K
  • RLYB 385.4K
  • Earning Date
  • MI 01-01-0001
  • RLYB 11-06-2025
  • Dividend Yield
  • MI N/A
  • RLYB N/A
  • EPS Growth
  • MI N/A
  • RLYB N/A
  • EPS
  • MI 1.53
  • RLYB N/A
  • Revenue
  • MI $740,701.00
  • RLYB $761,000.00
  • Revenue This Year
  • MI N/A
  • RLYB N/A
  • Revenue Next Year
  • MI N/A
  • RLYB N/A
  • P/E Ratio
  • MI $2.37
  • RLYB N/A
  • Revenue Growth
  • MI N/A
  • RLYB 154.51
  • 52 Week Low
  • MI $1.57
  • RLYB $0.22
  • 52 Week High
  • MI $10.29
  • RLYB $1.24
  • Technical
  • Relative Strength Index (RSI)
  • MI 56.36
  • RLYB 55.28
  • Support Level
  • MI $3.34
  • RLYB $0.58
  • Resistance Level
  • MI $4.30
  • RLYB $0.61
  • Average True Range (ATR)
  • MI 0.48
  • RLYB 0.04
  • MACD
  • MI 0.03
  • RLYB -0.00
  • Stochastic Oscillator
  • MI 55.19
  • RLYB 73.86

About MI NFT Limited

NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: